surface and when the tarsorraphy is opened there may be serious distortion of the lid mar gins resulting in further corneal damage. Many patients find the appearance disturbing and some find it uncomfortable. In other cases, bandage contact lenses may be an acceptable form of therapy but often their use may be contra-indicated, e.g. by severe blepharitis. Taping the lids shut may be a short term solution as may the use of the tissue adhesive to stick the lid margins together, but in most cases such devices are not tolerated for long periods because of skin irritation and they may provide inadequate corneal cover. Moreover, taping requires some degree of skill on the part of the patient if it is to be applied safely and effectively.
Botulinum toxin A is one of the eight toxins produced by Clostridium botulinum. The toxin is internalised into the presynaptic nerve. It then blocks acetylcholine release producing functional denervation of the muscle fibres for several weeks. New myo neural junctions are formed over 6 to 8 weeks and muscle activity returns to normal. The toxin does not induce scar tissue formation. ' This property has been used clinically since 1978 to produce temporary paresis of extra ocular muscles in the management of strabismus and of the orbicularis oculi muscles for essential blepharospasm. 2.3.4.5 It was noted, in many of the patients undergoing this treatment, that a temporary ptosis often resulted due to the infiltration of the levator palpebrae superioris muscle (LPS) with toxin. Recovery of muscle function is dependent on growth of a new motor end plate,6 a process which may be prolonged in the fast or twitch fibres found in the LPS7.
It was thought that if a ptosis could be delib erately produced by this method, it might Recovery times for levator function and lid position are from the time of the last injection.
* 1 this patient subsequently underwent tarsorraphy and eye movements could not fully be tested.
*2 this patient's palpebral fissure recovered to pre-injection levels 3 weeks after injection but levator function was still reduced by I mm. At this time further lid surgery was undertaken.
* 3 this patient's prophylactic treatment continues. Further injections to a maximum of four, in total, were given if a sufficient degree of ptosis did not develop in a week, if the effect began to wear off before full healing had taken place or if further protection was required.
Results
Fifteen patients were treated with BTPP. (Table I ). The time taken for maximum ptosis to develop varied from 30 hours to 10 days (mean 3 days) following injection. Ptosis was complete in 8 patients and complete corneal coverage was produced in a further 3 patients after injection, but a subsequent injection was necessary in 4 of the cases. (Fig. 2 Abbreviations. Bk-bullous keratopathy; cc-cicatrising conjunctivitis; csg-chronic simple glaucoma; hsk-herpes simplex keratitis; hzo-herpes zoster ophthalmicus; ipf-interpalpebral fissure, maximum width; LMN-lower motor neurone lesion of Vllth cranial nerve; npk-neuroparalytic keratitis; nyr-not yet recovered; pk-penetrating keratoplasty; sk-suppurative keratitis; 2Y secondary; + present; -absent. lasted from 7 days to 5 weeks (mean 2.5 weeks) before recovery began. Recovery took place up to a maximum time of 7 months (mean 8. 1 weeks) but the follow-up period of 3 patients is too short for full recovery to have taken place. In 10 cases, including the 4 men tioned above, further injections were given because healing was not complete or because continuing protection was necessary. (Fig. 3.) In the 13 cases where the lid closure was indicated because of a corneal epithelial defect, complete healing occurred in 10 cases and almost complete healing in one further case. Progression of the underlying condition, after an initially successful response (includ ing full re-epithelialisation of the defect in 2 cases), was seen in 4 cases, despite adequate corneal coverage. These cases included; a patient with Stevens-Johnson syndrome and a penetrating keratoplasty who had recurrent corneal epithelial defects with melting, a patient with uncontrolled sclerokeratitis and peripheral corneal melt and corneal graft and 2 patients with advanced cicatricial con junctivitis. One of these latter two patients represented the only failure of the procedure to produce complete closure of the lids despite complete covering of the epithelial defect. This was due to a notch at the medial aspect of the upper lid which led to exposure of the globe and subsequent ulceration which devel oped after the original defect had healed. A medial tarsorraphy was later performed which, interestingly, led to periorbital cel lulitis from a suture abscess. The final patient with cicatrising conjunctivitis developed a suppurative keratitis after the epithelial defect had healed.
Other complications did occur but in most cases were not serious and were self resolving. Preseptal haemorrhage occurred in one case. This had the beneficial effect of producing immediate closure of the lid! The most com mon complication found was underactivity of the ipsilateral superior rectus muscle. This was not unexpected due to the proximity of the superior rectus and the LPS. Temporary underactivity was observed in 12 cases, but in only 2 cases did the patient appreciate vertical diplopia as the lid began to open. Prisms were required for 3 months for relief of this symp tom by one patient and in the other patient full ocular motility was achieved after 5 months. Other induced muscle weakness was not found. In all cases the induced superior rectus weakness recovered fully in a mean of 6 weeks.
Discussion
Healing of epithelial defects in the cornea in the presence of neuroparalytic keratitis or other conditions where there are severe ocular surface abnormalities is often very dif ficult to achieve. None of the standard tech niques currently used to promote healing is without risk to the eye or the lid margins. Botulinum toxin A induced ptosis is an effec tive means of producing full corneal coverage and epithelial healing ensues rapidly. The flaccid paralysis of the LPS may have addi tional benefit in reducing the amount of lid movement without disturbing tear film spreading since the action of orbicularis oculi is unimpeded. The technique is simple and does not damage lid margin structures but it should be used with care when any scarring is suspected in the region of the LPS because adequate closure may not be produced. Similarly when there is likely to be inadequate closure due to cicatricial lid deformity, addi tional care and supervision may be required, but providing full closure can be achieved cicatricial disease need not be an absolute contraindication to BTPP. Since the flaccid lids may be easily opened, full examination is not hindered and any necessary medications may be instilled without difficulty and without the need to use preservative free solutions which would be preferable with bandage lenses.
As in the use of bandage contact lenses, scrupulous attention must be paid to the cleanliness of the lid margins since there may be a tLldency for pooling of the tear film which may predispose to infection. The disap pointing results in patients with advanced cicatrising cojunctivitis may reflect the poor defences on the ocular surface in these cases, but such patients are always at very high risk of developing acute exacerbations of their conditions.
Precise comparison with other techniques from the point of view of healing rates is diffi cult because of the varied nature of the under lying pathology and the small numbers involved, nevertheless epithelial defects appeared to heal very quickly with BTPP often where other techniques had failed.
The only associated abnormality of ocular motility was a temporary weakness of the superior rectus muscle which recovered com pletely in all cases. Scott2 noted in the ptosis developing in association with superior rectus injection of Botulinum toxin, that the ptosis may last 6 months or more following injec tion. Where follow-up is long enough, our figures suggest that levator function recovers to pre-injection levels within six months. Clearly BTPP is not suitable for permanent closure of the lids but it may provide valuable protection temporarily in cases before a decision can reasonably be made that a per manent tarsorraphy is indicated eg in cases of acoustic neuromata where there is fifth and seventh nerve damage at the time of surgery. The prophylactic use of BTPP may avoid tar sorraphy in many such cases.
Perhaps, surprisingly, patient acceptability was very high. All those who had practised taping said they preferred the BTPP. None was concerned by their cosmetic appearance.
The mechanism of action of corneal coverage leading to healing of defects in the corneal epithelium remains to be explained fully. It is thought that this is due to lack of movement because of the flaccid paralysis, but some relief of mechanical effect on the ocular surfaces might be expected. Whether reduction of lid motility aids this can only be speculative in the absence of biopsy material. Impression cytology may provide interesting data from these cases in whom biopsy is clearly contraindicated.
The new technique of Botulinum Toxin A induced protective ptosis may be useful in providing corneal protection or for promoting healing of corneal epithelial defects in long standing breakdown.
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